Peripheral Intravenous Catheters Market Size

Market Outlook:

Peripheral Intravenous Catheters Market crossed USD 5.56 Billion in 2023 and is poised to reach USD 11.23 Billion by end of the year 2032, witnessing more than 7.9% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 5.56 Billion
• CAGR (2024-2032): 7.9%
• Forecast Year Value (2032): USD 11.23 Billion
• Historical Data Period: 2019-2023
• Largest Region: North America
• Forecast Period: 2024-2032

Market Dynamics:

Growth Drivers & Opportunity:

One major growth driver for the Peripheral Intravenous Catheters Market is the increasing prevalence of chronic diseases and the growing demand for medical procedures that require intravenous therapy. As the global population continues to age and the incidence of diseases such as diabetes, cancer, and cardiovascular disorders rises, there is a greater need for peripheral intravenous catheters to administer medication and fluids to patients efficiently and safely.

Another key driver for market growth is the advancements in technology and the development of innovative catheter products that improve patient comfort and reduce the risk of catheter-related complications. Manufacturers are investing in research and development to create catheters with features such as antimicrobial coatings, safety mechanisms to prevent needlestick injuries, and materials that enhance catheter longevity and flexibility. These technological innovations are driving the adoption of peripheral intravenous catheters in healthcare settings.

Industry

Report Scope

Report Coverage	Details
Segments Covered	Product, Technology, Lumen, End-Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	AngioDynamics, Becton, Dickinson and Company, B. Braun Melsungen AG, Boston Scientific, ICU Medical, Lineus Medical, MedSource Labs, Retractable Technologies, Teleflex Incorporated, Terumo, VOGT Medical, Vygon

Despite the promising growth prospects for the Peripheral Intravenous Catheters Market, there are also significant restraints that could hinder market expansion. One major restraint is the stringent regulatory requirements for catheter manufacturing and usage, which can pose challenges for companies seeking to enter or expand in the market. Compliance with regulatory standards and obtaining necessary approvals can be time-consuming and costly, impacting market entry for new players and product launches for existing manufacturers.

Another key restraint for the market is the increasing concerns regarding catheter-associated infections and the need for healthcare facilities to implement strict protocols for catheter insertion, maintenance, and removal. Catheter-related bloodstream infections are a significant healthcare-associated complication that can lead to increased patient morbidities, hospital stays, and healthcare costs. Healthcare providers are under pressure to adhere to best practices for catheter care, which can limit the growth of the peripheral intravenous catheters market as facilities emphasize infection prevention measures over expansion of catheter use.